{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:54:21Z","timestamp":1793840061750,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboud Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jbspin.2020.105092","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:40:51Z","timestamp":1603888851000},"page":"105092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["The role of interleukin-1 family members in hyperuricemia and gout"],"prefix":"10.1016","volume":"88","author":[{"given":"Viola","family":"Kl\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2020.105092_bib0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2020.105092_bib0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0315","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2020.105092_bib0320","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of Interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2020.105092_bib0330","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","article-title":"Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1","volume":"36","author":"Gross","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2020.105092_bib0335","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1\u03b1 and IL-1\u03b2 recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0340","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/annrheumdis-2018-214656","article-title":"mTOR inhibition by metformin impacts monosodium urate crystal\u2013induced inflammation and cell death in gout: a prelude to a new add-on therapy?","volume":"78","author":"Vazirpanah","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0345","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4049\/jimmunol.1003746","article-title":"P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals","volume":"188","author":"Uratsuji","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0350","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s10067-019-04697-w","article-title":"Sirt1 inhibits gouty arthritis via activating PPARgamma","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0355","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.38747","article-title":"Contribution of mast cell-derived interleukin-1beta to uric acid crystal-induced acute arthritis in mice","volume":"66","author":"Reber","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0360","first-page":"i12","article-title":"The role of IL-1 in gout: from bench to bedside","volume":"57","author":"So","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2020.105092_bib0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nat New Biol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0370","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/art.25006","article-title":"Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta","volume":"60","author":"Joosten","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.105092_bib0375","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0380","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout is a chronic inflammatory disease in which high levels of Interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0385","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.1620910114","article-title":"Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway","volume":"114","author":"Crisan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2020.105092_bib0390","doi-asserted-by":"crossref","first-page":"e001015","DOI":"10.1136\/rmdopen-2019-001015","article-title":"Failure to reach uric acid target of<0.36mmol\/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality","volume":"5","author":"Perez Ruiz","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2020.105092_bib0395","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/ard.2009.109355","article-title":"Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis","volume":"68","author":"Torres","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0400","doi-asserted-by":"crossref","first-page":"e0185704","DOI":"10.1371\/journal.pone.0185704","article-title":"The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice","volume":"12","author":"Reber","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2020.105092_bib0405","first-page":"85","article-title":"Interleukin-1 receptor antagonist gene polymorphism in Taiwanese patients with gout","volume":"23","author":"Lo","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0410","first-page":"559","article-title":"Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1 beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis","volume":"78","author":"Matsukawa","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.jbspin.2020.105092_bib0415","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2010.145821","article-title":"Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGF beta 1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3","volume":"70","author":"Chen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0420","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jbspin.2020.105092_bib0425","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.4049\/jimmunol.152.11.5485","article-title":"Crystal-induced neutrophil activation. V. Differential production of biologically active IL-1 and IL-1 receptor antagonist","volume":"152","author":"Roberge","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0430","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820139.2016.1153651","article-title":"Cytokine profile in gout: inflammation driven by IL-6 and IL-18?","volume":"45","author":"Cavalcanti","year":"2016","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jbspin.2020.105092_bib0435","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.bbrc.2018.08.139","article-title":"High-mobility group box 1 is responsible for monosodium urate crystal-induced inflammation in human U937 macrophages","volume":"503","author":"Choe","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2020.105092_bib0440","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3346\/jkms.2013.28.9.1289","article-title":"Caspase-1 level in synovial fluid is high in patients with spondyloarthropathy but not in patients with gout","volume":"28","author":"Son","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jbspin.2020.105092_bib0445","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/ATVBAHA.119.313224","article-title":"Soluble uric acid promotes atherosclerosis via AMPK (AMP-activated protein kinase)\u00a0\u2013\u00a0Mediated inflammation","volume":"40","author":"Kimura","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0450","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2020.105092_bib0455","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/dc08-1710","article-title":"Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia","volume":"32","author":"Tr\u00f8seid","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbspin.2020.105092_bib0460","doi-asserted-by":"crossref","first-page":"13979","DOI":"10.1038\/s41598-018-32334-0","article-title":"15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice","volume":"8","author":"Ruiz-Miyazawa","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2020.105092_bib0465","doi-asserted-by":"crossref","first-page":"1028401","DOI":"10.1155\/2016\/1028401","article-title":"Potential of IL-33 for preventing the kidney injury via regulating the lipid metabolism in gout patients","volume":"2016","author":"Duan","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jbspin.2020.105092_bib0470","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fendo.2019.00036","article-title":"IL-33 ameliorates the development of MSU-induced inflammation through expanding MDSCs-Like Cells","volume":"10","author":"Shang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jbspin.2020.105092_bib0475","doi-asserted-by":"crossref","first-page":"e0178939","DOI":"10.1371\/journal.pone.0178939","article-title":"IL-33 and ST2 levels in chronic kidney disease: associations with inflammation, vascular abnormalities, cardiovascular events, and survival","volume":"12","author":"Gungor","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2020.105092_bib0480","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4049\/jimmunol.1400110","article-title":"Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa","volume":"192","author":"Hara","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0485","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/ijms20061257","article-title":"IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential","volume":"20","author":"Boutet","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jbspin.2020.105092_bib0490","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41590-019-0467-1","article-title":"IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease","volume":"20","author":"Hojen","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0495","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2020.105092_bib0500","doi-asserted-by":"crossref","first-page":"e13074","DOI":"10.1111\/acel.13074","article-title":"Short-term interleukin-37 treatment improves vascular endothelial function, endurance exercise capacity, and whole-body glucose metabolism in old mice","volume":"19","author":"Ballak","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.jbspin.2020.105092_bib0505","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1819672116","article-title":"Interleukin-37 monomer is the active form for reducing innate immunity","volume":"116","author":"Eisenmesser","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2020.105092_bib0510","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-015-3109-5","article-title":"IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response","volume":"35","author":"Zeng","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0515","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/annrheumdis-2018-eular.2269","article-title":"AB0084 elevated levels of il-37 are associated with tophus and suppressed the production of inflammatory cytokines in patients with gout","volume":"77","author":"Hong","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0520","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/annrheumdis-2019-216233","article-title":"Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout","volume":"79","author":"Kluck","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0525","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","article-title":"Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout","volume":"18","author":"Liu","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.105092_bib0530","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2018.01.001","article-title":"The enigmatic role of IL-38 in inflammatory diseases","volume":"39","author":"Garraud","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jbspin.2020.105092_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","article-title":"Plasma interleukin-38 in patients with rheumatoid arthritis","volume":"65","author":"Xu","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0540","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/annrheumdis-2018-eular.5599","article-title":"OP0170 Human il-38 reduces joint inflammation in a mouse model of gouty arthritis","volume":"77","author":"De Graaf","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0545","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105092_bib0550","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"Prevalence of contraindications and prescription of pharmacologic therapies for gout","volume":"124","author":"Keenan","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2020.105092_bib0555","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/key402","article-title":"Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial","volume":"58","author":"Janssen","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2020.105092_bib0560","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/M18-1167","article-title":"Relationship of Interleukin-1beta blockade with incident gout and serum uric acid levels: exploratory analysis of a randomized controlled trial","volume":"169","author":"Solomon","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2020.105092_bib0565","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0021-9258(17)49941-8","article-title":"PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis","volume":"295","author":"Powers","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2020.105092_bib0570","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1084\/jem.20151074","article-title":"Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy","volume":"212","author":"Kelly","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2020.105092_bib0575","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/JLB.MA1118-470RR","article-title":"Phosphoinositide-3 kinase gamma regulates caspase-1 activation and leukocyte recruitment in acute murine gout","volume":"106","author":"Tavares","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0580","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0585","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jbspin.2020.105092_bib0590","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105092_bib0595","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14728214.2018.1527899","article-title":"Expert opinion on emerging urate-lowering therapies","volume":"23","author":"Stamp","year":"2018","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jbspin.2020.105092_bib0600","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","article-title":"Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1beta and by the induction of endogenous IL-1Ra","volume":"75","author":"Joosten","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X20301998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X20301998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:27:21Z","timestamp":1761150441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X20301998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1297319X20301998"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.105092","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of interleukin-1 family members in hyperuricemia and gout","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.105092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105092"}}